Brookstone Capital Management
AEHR icon

Brookstone Capital Management’s Aehr Test Systems AEHR Stock Holding History

Brookstone Capital Management’s Portfolio AEHR Stock Details AEHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$292K Buy
2,928
+300
+11% +$27.5K ﹤0.01% 1120
2026
Q2 		$252K Buy
+2,628
New +$240K ﹤0.01% 1161

Other funds holding AEHR

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $57.2B AUM 42.49% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $234B AUM 43.58% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $33.4B AUM 56.97% 1-Year Est. Return

Brookstone Capital Management's AEHR Position: Q3 2026 in Review

Brookstone Capital Management increased its Aehr Test Systems (AEHR) stake by 11% in Q3 2026, buying an estimated $27.5K and bringing the position to 2,928 shares worth $292K. The position accounts for ﹤0.01% of the portfolio, ranked #1120.

Brookstone Capital Management first reported a position in AEHR in Q2 2026 and has held it in 2 quarters since. 222 funds tracked by Wall St. Rank hold AEHR as of Q3 2026.

  • Brookstone Capital Management held 2,928 shares of Aehr Test Systems worth $292K as of Q3 2026.
  • Brookstone Capital Management bought 300 Aehr Test Systems shares in Q3 2026, an estimated $27.5K.
  • Aehr Test Systems made up ﹤0.01% of Brookstone Capital Management's portfolio in Q3 2026, its #1120 holding.
  • Brookstone Capital Management first reported a position in Aehr Test Systems in Q2 2026 and has held it in 2 quarters since.
  • 222 funds tracked by Wall St. Rank held Aehr Test Systems as of Q3 2026.

Based on Brookstone Capital Management's 13F filing for Q3 2026, filed 22 Oct 2026.